|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.490 USD | +4.17% |
|
-6.96% | -35.60% |
| 07-07 | RBC Capital Trims CorMedix Price Target to $13 From $14, Maintains Outperform Rating | MT |
| 07-02 | CorMedix Names Elizabeth Hurlburt as Chief Operating, Commercial Officer | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Neutral | Bearish |
| Resistance | 8.05 | 8.96 | 9.68 |
| Spread/Res. | -6.96% | -16.41% | -22.62% |
| Spread/Supp. | +4.17% | +19.84% | +19.84% |
| Support | 7.19 | 6.25 | 6.25 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- CRMD Stock
- Charts CorMedix Inc.
Select your edition
All financial news and data tailored to specific country editions
